An Exploration of the Metabolic Profile of Mammary Ductal Carcinoma Cells upon Treatment with Docosahexaenoic Acid

Loading...
Thumbnail Image

Authors

Croasdell, Corey T.

Issue Date

2015

Type

Thesis

Language

en_US

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

In recent years, cancer has come to be thought of as a metabolic disease. The Warburg phenotype, characteristic of most cancer cells is postulated to confer survival advantages. Special attention has been paid to treatments that attenuate metabolic function in cancer. Docosahexaenoic Acid (DHA; 22:6; 6n-3) has been shown to depress mammary carcinoma survival in cell culture as well as animal models. DHA supplementation has been shown to diminish the bioenergetic profile of malignant cell lines in a dose dependent manner. In the current study, the location of DHA’s impact on oxidative phosphorylation will be investigated. This research will help to discern a possible mechanism for DHA, thus allowing for a more targeted approach in the search for compounds which may synergistically interact with DHA to inhibit cancer cell growth and proliferation.

Description

The University of Nevada, Reno Libraries will promptly respond to removal requests related to content that violates intellectual property laws, data protections, or has been uploaded without creator consent. Takedown notices should be directed to our ScholarWolf team (scholarwolf@library.unr.edu) with information about the object, including its full URL and the nature of your complaint.

Citation

Publisher

License

In Copyright(All Rights Reserved)

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN